Acadia Pharmaceuticals Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 24 →InsidersNo open-market buys. 6 insiders sold $2.1M, 0 of 18 sales on a 10b5-1 plan.→HoldersBaker Bros 24.9%BlackRock 13.1%State Street 5.3%→PeersClosest companies: AXSM, VRDN, BMRN→
From the filings
Figures
- Revenue
- $1.14Blast 12 months
- Net income
- $380.5Mlast 12 months
- Operating cash flow
- $123.5Mlast 12 months
- Cash and equivalents
- $385.0Mat the last balance sheet
- Shares outstanding
- 172.1M shareson issue